Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

By  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1133-1133

Oxford University Press

Access to resources Recommend Favorite

Phase I and II clinical trials of trastuzumab

By Baselga J.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 49-55

Springer Publishing Company

Access to resources Recommend Favorite

Eight-year results of a prospective non-randomised study on therapy of small breast cancer

By Rauschecker H.F.   Sauerbrei W.   Gatzemeier W.   Sauer R.   Schauer A.   Schmoor C.   Schumacher M.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 315-323

Elsevier

Access to resources Recommend Favorite

Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients - a prospective, comparative, non-randomised study

By Fiets W.E.   van Helvoirt R.P.   Nortier J.W.R.   van der Tweel I.   Struikmans H.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1081-1088

Elsevier

Access to resources Recommend Favorite

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

By Earle C.C.   Maroun J.A.  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1059-1064

Elsevier

Access to resources Recommend Favorite